Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

NCT02687139 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Kidney Cancer

Interventions

DRUG: 18F-DCFPyL
PROCEDURE: PET/CT

Sponsor

Johns Hopkins University